The global market for Fenofibrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Fenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels.

North American market for Fenofibrate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Fenofibrate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Fenofibrate include AbbVie, Lupin, Salix Pharmaceuticals, Vectura, Cipher Pharmaceuticals, Rhodes Pharmaceuticals, Impax Laboratories, Mylan, Teva, Sun Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fenofibrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fenofibrate.

The Fenofibrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fenofibrate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fenofibrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fenofibrate Market Report

Report Metric	Details
Report Name	Fenofibrate Market
Segment by Type	Tablet Capsule
Segment by Application	Hospital Drug Store
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AbbVie, Lupin, Salix Pharmaceuticals, Vectura, Cipher Pharmaceuticals, Rhodes Pharmaceuticals, Impax Laboratories, Mylan, Teva, Sun Pharmaceutical, Bausch Health, HETERO, Aurobindo Pharma, Cipla, Amneal Pharmaceuticals, Prinston Pharmaceutical, Dr. Reddys Laboratories, APOTEX, Glenmark
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fenofibrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fenofibrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fenofibrate Market report?

Ans: The main players in the Fenofibrate Market are AbbVie, Lupin, Salix Pharmaceuticals, Vectura, Cipher Pharmaceuticals, Rhodes Pharmaceuticals, Impax Laboratories, Mylan, Teva, Sun Pharmaceutical, Bausch Health, HETERO, Aurobindo Pharma, Cipla, Amneal Pharmaceuticals, Prinston Pharmaceutical, Dr. Reddys Laboratories, APOTEX, Glenmark

What are the Application segmentation covered in the Fenofibrate Market report?

Ans: The Applications covered in the Fenofibrate Market report are Hospital, Drug Store

What are the Type segmentation covered in the Fenofibrate Market report?

Ans: The Types covered in the Fenofibrate Market report are Tablet, Capsule

1 Fenofibrate Market Overview

1.1 Product Definition

1.2 Fenofibrate by Type

1.2.1 Global Fenofibrate Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablet

1.2.3 Capsule

1.3 Fenofibrate by Application

1.3.1 Global Fenofibrate Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Drug Store

1.4 Global Fenofibrate Market Size Estimates and Forecasts

1.4.1 Global Fenofibrate Revenue 2020-2031

1.4.2 Global Fenofibrate Sales 2020-2031

1.4.3 Global Fenofibrate Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Fenofibrate Market Competition by Manufacturers

2.1 Global Fenofibrate Sales Market Share by Manufacturers (2020-2025)

2.2 Global Fenofibrate Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Fenofibrate Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Fenofibrate, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Fenofibrate, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Fenofibrate, Product Type & Application

2.7 Global Key Manufacturers of Fenofibrate, Date of Enter into This Industry

2.8 Global Fenofibrate Market Competitive Situation and Trends

2.8.1 Global Fenofibrate Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Fenofibrate Players Market Share by Revenue

2.8.3 Global Fenofibrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Fenofibrate Market Scenario by Region

3.1 Global Fenofibrate Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Fenofibrate Sales by Region: 2020-2031

3.2.1 Global Fenofibrate Sales by Region: 2020-2025

3.2.2 Global Fenofibrate Sales by Region: 2026-2031

3.3 Global Fenofibrate Revenue by Region: 2020-2031

3.3.1 Global Fenofibrate Revenue by Region: 2020-2025

3.3.2 Global Fenofibrate Revenue by Region: 2026-2031

3.4 North America Fenofibrate Market Facts & Figures by Country

3.4.1 North America Fenofibrate Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Fenofibrate Sales by Country (2020-2031)

3.4.3 North America Fenofibrate Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Fenofibrate Market Facts & Figures by Country

3.5.1 Europe Fenofibrate Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Fenofibrate Sales by Country (2020-2031)

3.5.3 Europe Fenofibrate Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Fenofibrate Market Facts & Figures by Region

3.6.1 Asia Pacific Fenofibrate Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Fenofibrate Sales by Region (2020-2031)

3.6.3 Asia Pacific Fenofibrate Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Fenofibrate Market Facts & Figures by Country

3.7.1 Latin America Fenofibrate Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Fenofibrate Sales by Country (2020-2031)

3.7.3 Latin America Fenofibrate Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Fenofibrate Market Facts & Figures by Country

3.8.1 Middle East and Africa Fenofibrate Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Fenofibrate Sales by Country (2020-2031)

3.8.3 Middle East and Africa Fenofibrate Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Fenofibrate Sales by Type (2020-2031)

4.1.1 Global Fenofibrate Sales by Type (2020-2025)

4.1.2 Global Fenofibrate Sales by Type (2026-2031)

4.1.3 Global Fenofibrate Sales Market Share by Type (2020-2031)

4.2 Global Fenofibrate Revenue by Type (2020-2031)

4.2.1 Global Fenofibrate Revenue by Type (2020-2025)

4.2.2 Global Fenofibrate Revenue by Type (2026-2031)

4.2.3 Global Fenofibrate Revenue Market Share by Type (2020-2031)

4.3 Global Fenofibrate Price by Type (2020-2031)

5 Segment by Application

5.1 Global Fenofibrate Sales by Application (2020-2031)

5.1.1 Global Fenofibrate Sales by Application (2020-2025)

5.1.2 Global Fenofibrate Sales by Application (2026-2031)

5.1.3 Global Fenofibrate Sales Market Share by Application (2020-2031)

5.2 Global Fenofibrate Revenue by Application (2020-2031)

5.2.1 Global Fenofibrate Revenue by Application (2020-2025)

5.2.2 Global Fenofibrate Revenue by Application (2026-2031)

5.2.3 Global Fenofibrate Revenue Market Share by Application (2020-2031)

5.3 Global Fenofibrate Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AbbVie

6.1.1 AbbVie Company Information

6.1.2 AbbVie Description and Business Overview

6.1.3 AbbVie Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AbbVie Fenofibrate Product Portfolio

6.1.5 AbbVie Recent Developments/Updates

6.2 Lupin

6.2.1 Lupin Company Information

6.2.2 Lupin Description and Business Overview

6.2.3 Lupin Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Lupin Fenofibrate Product Portfolio

6.2.5 Lupin Recent Developments/Updates

6.3 Salix Pharmaceuticals

6.3.1 Salix Pharmaceuticals Company Information

6.3.2 Salix Pharmaceuticals Description and Business Overview

6.3.3 Salix Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Salix Pharmaceuticals Fenofibrate Product Portfolio

6.3.5 Salix Pharmaceuticals Recent Developments/Updates

6.4 Vectura

6.4.1 Vectura Company Information

6.4.2 Vectura Description and Business Overview

6.4.3 Vectura Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Vectura Fenofibrate Product Portfolio

6.4.5 Vectura Recent Developments/Updates

6.5 Cipher Pharmaceuticals

6.5.1 Cipher Pharmaceuticals Company Information

6.5.2 Cipher Pharmaceuticals Description and Business Overview

6.5.3 Cipher Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Cipher Pharmaceuticals Fenofibrate Product Portfolio

6.5.5 Cipher Pharmaceuticals Recent Developments/Updates

6.6 Rhodes Pharmaceuticals

6.6.1 Rhodes Pharmaceuticals Company Information

6.6.2 Rhodes Pharmaceuticals Description and Business Overview

6.6.3 Rhodes Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Rhodes Pharmaceuticals Fenofibrate Product Portfolio

6.6.5 Rhodes Pharmaceuticals Recent Developments/Updates

6.7 Impax Laboratories

6.7.1 Impax Laboratories Company Information

6.7.2 Impax Laboratories Description and Business Overview

6.7.3 Impax Laboratories Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Impax Laboratories Fenofibrate Product Portfolio

6.7.5 Impax Laboratories Recent Developments/Updates

6.8 Mylan

6.8.1 Mylan Company Information

6.8.2 Mylan Description and Business Overview

6.8.3 Mylan Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mylan Fenofibrate Product Portfolio

6.8.5 Mylan Recent Developments/Updates

6.9 Teva

6.9.1 Teva Company Information

6.9.2 Teva Description and Business Overview

6.9.3 Teva Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Teva Fenofibrate Product Portfolio

6.9.5 Teva Recent Developments/Updates

6.10 Sun Pharmaceutical

6.10.1 Sun Pharmaceutical Company Information

6.10.2 Sun Pharmaceutical Description and Business Overview

6.10.3 Sun Pharmaceutical Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Sun Pharmaceutical Fenofibrate Product Portfolio

6.10.5 Sun Pharmaceutical Recent Developments/Updates

6.11 Bausch Health

6.11.1 Bausch Health Company Information

6.11.2 Bausch Health Description and Business Overview

6.11.3 Bausch Health Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Bausch Health Fenofibrate Product Portfolio

6.11.5 Bausch Health Recent Developments/Updates

6.12 HETERO

6.12.1 HETERO Company Information

6.12.2 HETERO Description and Business Overview

6.12.3 HETERO Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.12.4 HETERO Fenofibrate Product Portfolio

6.12.5 HETERO Recent Developments/Updates

6.13 Aurobindo Pharma

6.13.1 Aurobindo Pharma Company Information

6.13.2 Aurobindo Pharma Description and Business Overview

6.13.3 Aurobindo Pharma Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Aurobindo Pharma Fenofibrate Product Portfolio

6.13.5 Aurobindo Pharma Recent Developments/Updates

6.14 Cipla

6.14.1 Cipla Company Information

6.14.2 Cipla Description and Business Overview

6.14.3 Cipla Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Cipla Fenofibrate Product Portfolio

6.14.5 Cipla Recent Developments/Updates

6.15 Amneal Pharmaceuticals

6.15.1 Amneal Pharmaceuticals Company Information

6.15.2 Amneal Pharmaceuticals Description and Business Overview

6.15.3 Amneal Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Amneal Pharmaceuticals Fenofibrate Product Portfolio

6.15.5 Amneal Pharmaceuticals Recent Developments/Updates

6.16 Prinston Pharmaceutical

6.16.1 Prinston Pharmaceutical Company Information

6.16.2 Prinston Pharmaceutical Description and Business Overview

6.16.3 Prinston Pharmaceutical Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Prinston Pharmaceutical Fenofibrate Product Portfolio

6.16.5 Prinston Pharmaceutical Recent Developments/Updates

6.17 Dr. Reddys Laboratories

6.17.1 Dr. Reddys Laboratories Company Information

6.17.2 Dr. Reddys Laboratories Description and Business Overview

6.17.3 Dr. Reddys Laboratories Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Dr. Reddys Laboratories Fenofibrate Product Portfolio

6.17.5 Dr. Reddys Laboratories Recent Developments/Updates

6.18 APOTEX

6.18.1 APOTEX Company Information

6.18.2 APOTEX Description and Business Overview

6.18.3 APOTEX Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.18.4 APOTEX Fenofibrate Product Portfolio

6.18.5 APOTEX Recent Developments/Updates

6.19 Glenmark

6.19.1 Glenmark Company Information

6.19.2 Glenmark Description and Business Overview

6.19.3 Glenmark Fenofibrate Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Glenmark Fenofibrate Product Portfolio

6.19.5 Glenmark Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Fenofibrate Industry Chain Analysis

7.2 Fenofibrate Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Fenofibrate Production Mode & Process Analysis

7.4 Fenofibrate Sales and Marketing

7.4.1 Fenofibrate Sales Channels

7.4.2 Fenofibrate Distributors

7.5 Fenofibrate Customer Analysis

8 Fenofibrate Market Dynamics

8.1 Fenofibrate Industry Trends

8.2 Fenofibrate Market Drivers

8.3 Fenofibrate Market Challenges

8.4 Fenofibrate Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AbbVie

Lupin Ltd

Salix Pharmaceuticals

Vectura

Cipher Pharmaceuticals

Rhodes Pharmaceuticals

Amneal Pharmaceuticals

Prinston Pharmaceutical

Dr Reddys Laboratories

Apotex

Glenmark

List of Tables

Table 1. Global Fenofibrate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Fenofibrate Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Fenofibrate Market Competitive Situation by Manufacturers in 2024

Table 4. Global Fenofibrate Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Fenofibrate Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Fenofibrate Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Fenofibrate Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Fenofibrate Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Fenofibrate, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Fenofibrate, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Fenofibrate, Product Type & Application

Table 12. Global Key Manufacturers of Fenofibrate, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Fenofibrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fenofibrate as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Fenofibrate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Fenofibrate Sales by Region (2020-2025) & (K Units)

Table 18. Global Fenofibrate Sales Market Share by Region (2020-2025)

Table 19. Global Fenofibrate Sales by Region (2026-2031) & (K Units)

Table 20. Global Fenofibrate Sales Market Share by Region (2026-2031)

Table 21. Global Fenofibrate Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Fenofibrate Revenue Market Share by Region (2020-2025)

Table 23. Global Fenofibrate Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Fenofibrate Revenue Market Share by Region (2026-2031)

Table 25. North America Fenofibrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Fenofibrate Sales by Country (2020-2025) & (K Units)

Table 27. North America Fenofibrate Sales by Country (2026-2031) & (K Units)

Table 28. North America Fenofibrate Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Fenofibrate Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Fenofibrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Fenofibrate Sales by Country (2020-2025) & (K Units)

Table 32. Europe Fenofibrate Sales by Country (2026-2031) & (K Units)

Table 33. Europe Fenofibrate Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Fenofibrate Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Fenofibrate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Fenofibrate Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Fenofibrate Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Fenofibrate Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Fenofibrate Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fenofibrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Fenofibrate Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Fenofibrate Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Fenofibrate Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Fenofibrate Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Fenofibrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Fenofibrate Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Fenofibrate Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Fenofibrate Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Fenofibrate Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Fenofibrate Sales (K Units) by Type (2020-2025)

Table 51. Global Fenofibrate Sales (K Units) by Type (2026-2031)

Table 52. Global Fenofibrate Sales Market Share by Type (2020-2025)

Table 53. Global Fenofibrate Sales Market Share by Type (2026-2031)

Table 54. Global Fenofibrate Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Fenofibrate Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Fenofibrate Revenue Market Share by Type (2020-2025)

Table 57. Global Fenofibrate Revenue Market Share by Type (2026-2031)

Table 58. Global Fenofibrate Price (USD/Unit) by Type (2020-2025)

Table 59. Global Fenofibrate Price (USD/Unit) by Type (2026-2031)

Table 60. Global Fenofibrate Sales (K Units) by Application (2020-2025)

Table 61. Global Fenofibrate Sales (K Units) by Application (2026-2031)

Table 62. Global Fenofibrate Sales Market Share by Application (2020-2025)

Table 63. Global Fenofibrate Sales Market Share by Application (2026-2031)

Table 64. Global Fenofibrate Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Fenofibrate Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Fenofibrate Revenue Market Share by Application (2020-2025)

Table 67. Global Fenofibrate Revenue Market Share by Application (2026-2031)

Table 68. Global Fenofibrate Price (USD/Unit) by Application (2020-2025)

Table 69. Global Fenofibrate Price (USD/Unit) by Application (2026-2031)

Table 70. AbbVie Company Information

Table 71. AbbVie Description and Business Overview

Table 72. AbbVie Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. AbbVie Fenofibrate Product

Table 74. AbbVie Recent Developments/Updates

Table 75. Lupin Company Information

Table 76. Lupin Description and Business Overview

Table 77. Lupin Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Lupin Fenofibrate Product

Table 79. Lupin Recent Developments/Updates

Table 80. Salix Pharmaceuticals Company Information

Table 81. Salix Pharmaceuticals Description and Business Overview

Table 82. Salix Pharmaceuticals Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Salix Pharmaceuticals Fenofibrate Product

Table 84. Salix Pharmaceuticals Recent Developments/Updates

Table 85. Vectura Company Information

Table 86. Vectura Description and Business Overview

Table 87. Vectura Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Vectura Fenofibrate Product

Table 89. Vectura Recent Developments/Updates

Table 90. Cipher Pharmaceuticals Company Information

Table 91. Cipher Pharmaceuticals Description and Business Overview

Table 92. Cipher Pharmaceuticals Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Cipher Pharmaceuticals Fenofibrate Product

Table 94. Cipher Pharmaceuticals Recent Developments/Updates

Table 95. Rhodes Pharmaceuticals Company Information

Table 96. Rhodes Pharmaceuticals Description and Business Overview

Table 97. Rhodes Pharmaceuticals Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Rhodes Pharmaceuticals Fenofibrate Product

Table 99. Rhodes Pharmaceuticals Recent Developments/Updates

Table 100. Impax Laboratories Company Information

Table 101. Impax Laboratories Description and Business Overview

Table 102. Impax Laboratories Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Impax Laboratories Fenofibrate Product

Table 104. Impax Laboratories Recent Developments/Updates

Table 105. Mylan Company Information

Table 106. Mylan Description and Business Overview

Table 107. Mylan Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Mylan Fenofibrate Product

Table 109. Mylan Recent Developments/Updates

Table 110. Teva Company Information

Table 111. Teva Description and Business Overview

Table 112. Teva Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Teva Fenofibrate Product

Table 114. Teva Recent Developments/Updates

Table 115. Sun Pharmaceutical Company Information

Table 116. Sun Pharmaceutical Description and Business Overview

Table 117. Sun Pharmaceutical Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Sun Pharmaceutical Fenofibrate Product

Table 119. Sun Pharmaceutical Recent Developments/Updates

Table 120. Bausch Health Company Information

Table 121. Bausch Health Description and Business Overview

Table 122. Bausch Health Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Bausch Health Fenofibrate Product

Table 124. Bausch Health Recent Developments/Updates

Table 125. HETERO Company Information

Table 126. HETERO Description and Business Overview

Table 127. HETERO Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. HETERO Fenofibrate Product

Table 129. HETERO Recent Developments/Updates

Table 130. Aurobindo Pharma Company Information

Table 131. Aurobindo Pharma Description and Business Overview

Table 132. Aurobindo Pharma Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Aurobindo Pharma Fenofibrate Product

Table 134. Aurobindo Pharma Recent Developments/Updates

Table 135. Cipla Company Information

Table 136. Cipla Description and Business Overview

Table 137. Cipla Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Cipla Fenofibrate Product

Table 139. Cipla Recent Developments/Updates

Table 140. Amneal Pharmaceuticals Company Information

Table 141. Amneal Pharmaceuticals Description and Business Overview

Table 142. Amneal Pharmaceuticals Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Amneal Pharmaceuticals Fenofibrate Product

Table 144. Amneal Pharmaceuticals Recent Developments/Updates

Table 145. Prinston Pharmaceutical Company Information

Table 146. Prinston Pharmaceutical Description and Business Overview

Table 147. Prinston Pharmaceutical Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Prinston Pharmaceutical Fenofibrate Product

Table 149. Prinston Pharmaceutical Recent Developments/Updates

Table 150. Dr. Reddys Laboratories Company Information

Table 151. Dr. Reddys Laboratories Description and Business Overview

Table 152. Dr. Reddys Laboratories Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Dr. Reddys Laboratories Fenofibrate Product

Table 154. Dr. Reddys Laboratories Recent Developments/Updates

Table 155. APOTEX Company Information

Table 156. APOTEX Description and Business Overview

Table 157. APOTEX Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. APOTEX Fenofibrate Product

Table 159. APOTEX Recent Developments/Updates

Table 160. Glenmark Company Information

Table 161. Glenmark Description and Business Overview

Table 162. Glenmark Fenofibrate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 163. Glenmark Fenofibrate Product

Table 164. Glenmark Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Fenofibrate Distributors List

Table 168. Fenofibrate Customers List

Table 169. Fenofibrate Market Trends

Table 170. Fenofibrate Market Drivers

Table 171. Fenofibrate Market Challenges

Table 172. Fenofibrate Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Fenofibrate

Figure 2. Global Fenofibrate Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fenofibrate Market Share by Type: 2024 & 2031

Figure 4. Tablet Product Picture

Figure 5. Capsule Product Picture

Figure 6. Global Fenofibrate Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Fenofibrate Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Drug Store

Figure 10. Global Fenofibrate Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Fenofibrate Market Size (2020-2031) & (US$ Million)

Figure 12. Global Fenofibrate Sales (2020-2031) & (K Units)

Figure 13. Global Fenofibrate Average Price (USD/Unit) & (2020-2031)

Figure 14. Fenofibrate Report Years Considered

Figure 15. Fenofibrate Sales Share by Manufacturers in 2024

Figure 16. Global Fenofibrate Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Fenofibrate Players: Market Share by Revenue in Fenofibrate in 2024

Figure 18. Fenofibrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Fenofibrate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Fenofibrate Sales Market Share by Country (2020-2031)

Figure 21. North America Fenofibrate Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Fenofibrate Sales Market Share by Country (2020-2031)

Figure 25. Europe Fenofibrate Revenue Market Share by Country (2020-2031)

Figure 26. Germany Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Fenofibrate Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Fenofibrate Revenue Market Share by Region (2020-2031)

Figure 33. China Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Fenofibrate Sales Market Share by Country (2020-2031)

Figure 44. Latin America Fenofibrate Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Fenofibrate Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Fenofibrate Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Fenofibrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Fenofibrate by Type (2020-2031)

Figure 54. Global Revenue Market Share of Fenofibrate by Type (2020-2031)

Figure 55. Global Fenofibrate Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Fenofibrate by Application (2020-2031)

Figure 57. Global Revenue Market Share of Fenofibrate by Application (2020-2031)

Figure 58. Global Fenofibrate Price (USD/Unit) by Application (2020-2031)

Figure 59. Fenofibrate Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22I19939

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38W19812

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39V16824

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions